Extracellular Endothelial Cell-Derived Vesicles: Emerging Role in Cardiac and Vascular Remodeling in Heart Failure

por Berezin, Alexander E., Berezin, Alexander A.
Publicado 2020

Circulating Cardiac Biomarkers in Diabetes Mellitus: A New Dawn for Risk Stratification—A Narrative Review

por Berezin, Alexander E., Berezin, Alexander A.
Publicado 2020

Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers

por Berezin, Alexander E., Berezin, Alexander A.
Publicado 2020

Extracellular Vesicles and Thrombogenicity in Atrial Fibrillation

por Berezin, Alexander E., Berezin, Alexander A.
Publicado 2022

Biomarkers in Heart Failure: From Research to Clinical Practice

por Berezin, Alexander E., Berezin, Alexander A.
Publicado 2023

Emerging Role of Adipocyte Dysfunction in Inducing Heart Failure Among Obese Patients With Prediabetes and Known Diabetes Mellitus

por Berezin, Alexander E., Berezin, Alexander A., Lichtenauer, Michael
Publicado 2020

Myokines and Heart Failure: Challenging Role in Adverse Cardiac Remodeling, Myopathy, and Clinical Outcomes

por Berezin, Alexander E., Berezin, Alexander A., Lichtenauer, Michael
Publicado 2021

Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients

por Berezin, Alexander A., Fushtey, Ivan M., Berezin, Alexander E.
Publicado 2022

The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure

por Berezin, Alexander A., Fushtey, Ivan M., Berezin, Alexander E.
Publicado 2022

Epigenetics in heart failure phenotypes()

por Berezin, Alexander
Publicado 2016

Stable Coronary Artery Disease Patients: Different Practice Patterns in Everyday Clinical Situations

por Berezin, Alexander E.
Publicado 2015

Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers

por Berezin, Alexander E.
Publicado 2016

Discriminative Value of Serum Irisin in Prediction of Heart Failure with Different Phenotypes among Patients with Type 2 Diabetes Mellitus

por Berezin, Alexander A., Lichtenauer, Michael, Boxhammer, Elke, Stöhr, Eric, Berezin, Alexander E.
Publicado 2022

Predictive value of serum irisin for chronic heart failure in patients with type 2 diabetes mellitus

por Berezin, Alexander A., Fushtey, Ivan M., Pavlov, Sergii V., Berezin, Alexander E.
Publicado 2022

Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus

por Berezin, Alexander A., Lichtenauer, Michael, Boxhammer, Elke, Fushtey, Ivan M., Berezin, Alexander E.
Publicado 2022

Adropin Predicts Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure

por Berezina, Tetiana A., Obradovic, Zeljko, Boxhammer, Elke, Berezin, Alexander A., Lichtenauer, Michael, Berezin, Alexander E.
Publicado 2023

Interplay between Myokine Profile and Glycemic Control in Type 2 Diabetes Mellitus Patients with Heart Failure

por Berezin, Alexander A., Obradovic, Zeljko, Novikov, Evgen V., Boxhammer, Elke, Lichtenauer, Michael, Berezin, Alexander E.
Publicado 2022

Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines

por Berezin, Alexander A., Obradovic, Zeljko, Berezina, Tetiana A., Boxhammer, Elke, Lichtenauer, Michael, Berezin, Alexander E.
Publicado 2023

Low Plasma Levels of Irisin Predict Acutely Decompensated Heart Failure in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure

por Berezin, Alexander A., Obradovic, Anica Babic, Fushtey, Ivan M., Berezina, Tetiana A, Lichtenauer, Michael, Berezin, Alexander E
Publicado 2023

The Association of Glucose Control with Circulating Levels of Red Blood Cell-Derived Vesicles in Type 2 Diabetes Mellitus Patients with Atrial Fibrillation

por Berezin, Alexander A., Obradovic, Zeljko, Kopp, Kristen, Berezina, Tetiana A., Lichtenauer, Michael, Wernly, Bernhard, Berezin, Alexander E.
Publicado 2022